Resources from the same session
LBA72 - Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
Presenter: Petros Grivas
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA73 - The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01
Presenter: Pia Kvistborg
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA74 - Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS)
Presenter: Deborah Doroshow
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA75 - Defining COVID-19 outcomes in thoracic cancer patients: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion)
Presenter: Javier Baena Espinar
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA72 and LBA73
Presenter: Emanuela Romano
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Slides
Webcast
Invited Discussant LBA74 and LBA75
Presenter: Antonio Passaro
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Slides
Webcast